Factors associated with glycemic control in patients with T2DM: evidence from a cross-sectional study in China

被引：0
作者：
Luo, Wenting [1 ]
Zhang, Jiayu [2 ]
Luo, Yanxing [3 ]
Wu, Qiuwan [1 ]
Chen, Longfei [1 ]
Liu, Changqin [4 ]
Lin, Minqiang [1 ,5 ]
机构：
[1] Xiamen Univ, Affiliated Hosp 1, Sch Med, Dept Sci Res, 24 Bailu Rd, Xiamen 361003, Fujian, Peoples R China
[2] Xiamen Univ, Affiliated Hosp 1, Sch Med, Dept Intens Care Med, Xiamen 361003, Peoples R China
[3] Fujian Med Univ, Sch Publ Hlth, Fuzhou 350122, Peoples R China
[4] Xiamen Univ, Affiliated Hosp 1, Sch Med, Dept Endocrinol & Diabet, Xiamen 361003, Peoples R China
[5] Xiamen Univ, Affiliated Hosp 1, Inst Clin Med Res, Sch Med, Xiamen 361003, Peoples R China
来源：
BMC ENDOCRINE DISORDERS | 2024年 / 24卷 / 01期
关键词：
Diabetes; Patient management; Glucose control; Influencing factors;
D O I：
10.1186/s12902-024-01605-5
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Objective This study aimed to analyze the factors influencing glycemic control in patients with type 2 diabetes mellitus (T2DM).Methods Baseline data, encompassing basic information, lifestyle habits, and treatment of 305 T2DM patients from March 2021 to January 2023, were collected and analyzed using SPSS 26.0 software.Results Univariate and multivariate logistic regression analyses identified insulin therapy (OR = 2.233; 95%Cl = 1.013-4.520; P = 0.026) and regular clinic visits (OR = 0.567; 95%Cl = 0.330-0.973; P = 0.040) as independent factors influencing glycemic control. No observed interactions between the two variables were noted.Conclusion History of insulin therapy and regular clinic visits were significantly and independently associated with glycated hemoglobin control in T2DM patients. Tailored interventions based on individual circumstances are recommended to optimize glycemic control.
引用
收藏
页数：8
相关论文
共 18 条
  • [1] Al-Qerem W, 2022, EUR REV MED PHARMACO, V26, P2415, DOI 10.26355/eurrev_202204_28475
  • [2] Evaluation of a Pharmacist-Managed Diabetes Program in a Primary Care Setting Within an Integrated Health Care System
    Benedict, Amanda W.
    Spence, Michele M.
    Sie, John L.
    Chin, Helen A.
    Ngo, Chi D.
    Salmingo, Jennifer F.
    Vidaurreta, Andrew T.
    Rashid, Nazia
    [J]. JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2018, 24 (02) : 114 - +
  • [3] Chen XB, 2020, China Gen Med, V23, P837
  • [4] Christ-Crain M, 2019, NAT REV DIS PRIMERS, V5, DOI [10.1038/s41572-019-0114-z, 10.1038/s41572-019-0103-2]
  • [5] Clinical guidelines for prevention and treatment of type 2 diabetes mellitus in the elderly in China (2022 edition), Zhonghua Nei Ke Za Zhi, V61, P12, DOI [DOI 10.3760/CMA.J.CN112138-20211027-00751, 10.3760/cma.j.cn112138-20211027-00751]
  • [6] Feng JJ, 2015, China Health Educ, P508
  • [7] Poor glycemic control and its associated factors among children with type 1 diabetes mellitus in Harar, eastern Ethiopia: A cross-sectional study
    Habteyohans, Betelhem Demeke
    Hailu, Betre Shimelis
    Meseret, Fentahun
    Mohammed, Ahmed
    Berhanu, Yeshi
    Alemu, Ayichew
    Tolosa, Gadissa
    Keneni, Mulualem
    Desalew, Assefa
    [J]. BMC ENDOCRINE DISORDERS, 2023, 23 (01)
  • [8] Hu X., 2022, Shandong Med J, V62, P89
  • [9] Jarab AS, 2023, EUR REV MED PHARMACO, V27, P5775, DOI 10.26355/eurrev_202306_32816
  • [10] Poor glycemic control, cardiovascular disease risk factors and their clustering among patients with type 2 diabetes mellitus: A cross- sectional study from Nepal
    Khanal, Mahesh Kumar
    Bhandari, Pratiksha
    Dhungana, Raja Ram
    Gurung, Yadav
    Rawal, Lal B.
    Pandey, Gyanendra
    Bhandari, Madan
    Devkota, Surya
    de Courten, Maximilian
    de Courten, Barbora
    [J]. PLOS ONE, 2022, 17 (07):
12